Financials
- Market Capitalization 15.76 M
- Employee 29
- Founded 1986
- CEO Carl Spana
- Website www.palatin.com
- Headquarter New Jersey, United States
- FIGI BBG000BN9PY4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
4.79
ratio cours/chiffre d'affaires
1.91
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4696 | PASG Passage Bio, Inc. - Common Stock | 4.95 USD | +11.49% | +2.70% | -13.16% | -44.00% | 15.88 M USD | ||
| 4697 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.07 USD | +9.18% | +5.94% | -13.71% | -55.23% | 15.84 M USD | ||
| 4705 | QNCX Quince Therapeutics, Inc. - Common Stock | 18.58 USD | -3.68% | +6.29% | +1987.64% | +1026.06% | 15.14 M USD | ||
| 4717 | LEXX Lexaria Bioscience Corp. - Common Stock | 0.59 USD | 0.00% | -3.28% | +1.72% | -33.71% | 14.62 M USD |